Our use of cookies
We would like to use necessary cookies to perform the basic functions of this website. Such strictly necessary cookies do not require your consent and are therefore always active. We would also like to set analytical cookies and advertising cookies that help us make improvements by measuring how you use our website. Both the analytical cookies and advertising cookies require your consent and are therefore called “optional cookies”. Detailed information about the use of cookies and how you can control your consent for optional cookies can be found in our Cookie Policy and Privacy Policy.

Hello! We use cookies to help improve your experience of our website. With your consent, statistical and analytical cookies may also be used on this website. If you agree to the use of these additional cookies, please mark your choice:
8YcRYDxmluabBvjal85rH1DZ0A27Y8Aavw1ApaMr.webp

09.01 - 12.01.2024

Meet MGI Team at the 12th Edition of the Assises de Génétique Humaine et Médicale in Paris

Join us at booth 19 with MGI Tech during the Assises de Génétique Humaine et Médicale from January 9 to January 12, 2024 at Palais de Congrès in Paris.

eEJbWrlaJcvoS2nU35S1Tg6FBJiJRCygAFwigEij.webp

01.12.2023

World AIDS Day: SAMRC's Groundbreaking Study with MGI's DNBSEQ Technology

On World AIDS Day, we reflect on global progress in HIV/AIDS research, including SAMRC's use of MGI's DNBSEQ technology to identify genetic variations in rare HIV phenotypes.

E2yDF00way0JVVEG3DlmxLdlIH5BFJh1c6fCuEZ7.webp

23.11 - 25.11.2023

Successful Collaboration and Workshop: NGS in the Modern Clinical Lab

We successfully co-organized the 'NGS in the Modern Clinical Lab' workshop in Athens, showcasing MGI's groundbreaking innovations in genomics and sequencing technologies.

mhZmVDmew3XFNhOPbUQ67BkiLVvM1daMDW71RL0a.png

10.11 - 11.11.2023

Latvia MGI Tech SIA Advances DNA Methylation Research with Significant European Funding

Latvia MGI Tech SIA advances DNA methylation research with significant European funding, achieving groundbreaking progress in biotechnology and innovation

DAPaXHc0d1VT7TvbLmAfvrFd9G1sLxNBtKg9wryN.png

09.11 - 10.11.2023

NextGen Omics Event in London: A Confluence of Technology and Insights

MGI Tech had a fruitful presence at the NextGen Omics conference in London, showcasing our commitment to advancing genomics and fostering collaboration in the field.

WNK6eUUH4uQsZnjgons1epqPm8SWwHSOT08ma87S.png

03.11.2023

The Inaugural IVT-MGI Conference: Unveiling the Future of Omics and Genomic Technologies in Istanbul

Explore the future of Omics with MGI's cutting-edge products showcased at the First IVT-MGI Conference in Istanbul on November 3rd. Stay tuned for transformative updates on this scientific journey!

QEqqddSEwIdZaj4aBh76FCENVQ2WQJYH64Vstaiu.png

02.11 - 06.11.2023

MGI at the 14th AORTIC International Cancer Conference in Senegal

Explore the 14th AORTIC International Cancer Conference highlights in Dakar, Senegal, where MGI's local team showcased our commitment to life science innovation and the potential of our cutting-edge technologies in advancing NGS research and cancer diagnostics.

XEhcOgdSW2A9kjfjh3Ab3qzFIGtA4ojgsZTgRKZ9.jpg

19.10.2023

MGI Introduces Next-Generation Sequencing to Riga 3rd Gymnasium Students

MGI introduced the future of genomics to Riga 3rd Gymnasium students, offering hands-on experience with the cutting-edge DNBSEQ-T10 Next-Generation Sequencing technology to inspire and cultivate the next generation of scientists.

VgsyR4mbjf57lpKjyJzTo0DX0IMWrMBLnGJfgHxB.jpg

09.10 - 13.10.2023

MGI's Impact at the AfricaBP Workshop in Morocco

MGI left a lasting impact at the AfricaBP Workshop in Morocco, fostering collaboration in genomics and contributing to biodiversity research through its innovative DNBSEQ Technology.

lpBraaxOmTqDw4oF5ekqp5NZfFsVCee60LITbEc7.png

04.10 - 06.10.2023

DNBSEQ-G99 Debut in France at MICROBES 2023 Event

Explore the groundbreaking DNBSEQ-G99, our newly introduced mid-throughput sequencer, which made its debut at MICROBES 2023 in Rennes, France, offering exceptional accuracy for low to mid-throughput sequencing in metagenomics projects.

KvdLXJXZ7wjCtCva2aV6qOafz5vGb7JxehXt0v0v.png

16.08.2023

SpaTial Enhanced REsolution Omics-sequencing New Frontiers of Spatial Multi-omics - Webinar

We are thrilled to introduce our newest webinar in the "Genomics Unlocked" series: "SpaTial Enhanced REsolution Omics-sequencing New Frontiers of Spatial Multi-omics"

H6JF21FpSTSqgGV5XcsI0pEW0wmDB03WrQEADlwr.png

10.07.2023

MGI's DNBSEQ-T20*x2 Wins 2023 Globee® Awards for Medical Equipment

Explore MGI's latest achievement as its DNBSEQ-T20×2 gene sequencing platform wins the prestigious Globee® for Medical Equipment in the 15th Annual 2023 Golden Bridge Business and Innovation Awards®. This post highlights MGI's commitment to innovation in the life science industry, their groundbreaking T20 gene sequencer, and how their technology is reshaping healthcare outcomes and the genetic industry.

tee273xLNe5MxMB1M5HxuFKGYQkhuK4KthVmXMGS.jpg

14.06.2023

Unveiling MGI's Groundbreaking Innovations at the ESHG Conference in Glasgow

Discover the groundbreaking partnerships and innovations unveiled by MGI Tech Co., Ltd. at the ESHG Conference in Glasgow. Learn about MGI's strategic collaborations in the European life sciences market, their advancements in sequencing and automation technologies, and their commitment to revolutionizing genomics research. This post also highlights MGI's strategic partnership with Alithea Genomics, aiming to innovate in RNA sequencing.

g8CwIb0BTQfR9HWerDbL53gOhfwhIAzhDTZw6aXK.jpg

09.06.2023

MGI and AddLife AB: A Strategic Collaboration to Revolutionize Life Science in the Nordic Region

Discover the strategic collaboration between MGI Tech Co. Ltd., a global leader in life science technology, and AddLife AB, a major European distributor of clinical testing and laboratory equipment. Learn how this partnership aims to revolutionize life science in the Nordic region through the distribution of MGI's innovative products and expansion into fields like point-of-care testing and remote ultrasound.

3IpC9cVNmUHebIjvmqXRG1UwP0GUyd2mKWcjLuIj.jpg

12.05.2023

MGI's DNBSEQ-T20×2* Wins BEYOND Healthcare Innovation Award

MGI's award-winning DNBSEQ-T20×2* gene sequencing platform revolutionizes DNA sequencing in healthcare, offering unparalleled throughput and cost-efficiency for researchers and clinicians.

BHUW2i8JVrCms3M1FnuJLRsSZUJfcdLeJJ8UJfYQ.png

09.05.2023

Pioneering Microbiome Research with the Million Microbiome of Humans Project

Explore MGI Tech Co. Ltd.'s significant contributions to the Million Microbiome of Humans Project (MMHP), a collaborative effort aiming to construct a comprehensive microbiome map of the human body. This post highlights MGI's innovative sequencing technology, the importance of microbiome in human health, and the future of microbiomics in precision medicine. Discover how MGI is reshaping the future of microbiome research and healthcare.

JrMJoPeITU1voELNW4J6Jw6qfQ5F4YeoODKXm04o.jpg

08.05.2023

MGI Launches Overseas Production Line of DNBSEQ-G400* Sequencer in Latvia

MGI Tech Co., Ltd. launches an overseas production line in Latvia to assemble the advanced DNBSEQ-G400* gene sequencing instruments and HotMPS** reagents, marking a significant milestone in MGI's expansion into the European market.

jV2JoiIAVhxZez31st5MVnuu0r9utoIxgxd3DDrn.jpg

16.04.2023

Revolutionizing Genomics: How MGI Spurs Healthy Market Competition, Insights from GNOMIX's Chief Scientist

GNOMIX, a global genetics lab renowned for its diverse services, embraces MGI's role in stimulating market competition and shaping the genomics sector.

EFhykKxIPATMQPbFyjdrPQhRWFwKlPFbad8niaN6.jpg

08.03.2023

MGI Empowers European Genomics with the Launch of MGISP-Smart 8 and Empowerment Program at MEDICA

Celebrating the MGISP-Smart 8's European launch and our Empowerment Program at MEDICA, MGI continues to pioneer genomics research through steadfast innovation.

60VHLm10AoErHaCKHK8aW9fjZMmQ6MIGImrjz76p.png

25.02.2023

MGI Announces Commercial Launch of HotMPS High-Throughput Sequencing Kit* and Instrument** in Germany

"We are delighted to be bringing our proven DNBSEQ™ technology to customers and partners in Germany once again," said Dr. Yong Hou.

IGUdTgUP6pLsW7CVd7hk9jXVkrtNxXCi80YXxvq8.png

16.02.2023

Accelerated and Enhanced Virus Sequencing Achieved at Latvian Biomedical Research Center using the MGI Sequencing Platform

Latvian Biomedical Research Center Uses MGI's Sequencing Platform for Faster and More Efficient Virus Sequencing in the Fight against the Global Pandemic.

DDps5QNv5NDoU7QyGeQUfwIsfUe2Y4ndI94tuekI.png

02.01.2023

MGI Partners with ALACRiS Theranostics to Open New Customer Experience Center in Germany

Unveiling MGI's Customer Experience Center in Berlin: Empowering Precision Medicine. Explore MGI's new Customer Experience Center in Berlin, Germany, fostering precision medicine through innovative automation and sequencing. Revolutionize cancer diagnostics, personalized oncology services, and cutting-edge technologies.

MhfeVAP1dRRPLMbxpia9AcK2Omx7qvwzim7dmYcs.jpg

30.11.2022

User Voice | Turkish Genetic Disease Diagnosis Center: MGI’s sequencing technology and platform can provide us with more stable and accurate data results

NGC, a top genetic disease diagnosis center in Turkey, utilizes MGI's sequencing technology and platform for stable and accurate data results in their high-quality genetic testing services.

QZgDoNMx82H2RdYzpEnvvAkPfhA9geQesOKvwN4E.jpg

30.09.2022

Breakthroughs in Agrigenomics: MGI Revolutionizes Molecular Breeding

MGI Revolutionizes Agrigenomics Research and Molecular Breeding with Advanced Sequencing Technology and Platforms. Discover the Future of Agriculture with MGI's Innovations.